Literature DB >> 18631344

Sustained response after reduced-intensity conditioning allogeneic stem cell transplantation for patients with relapsed peripheral T-cell non-Hodgkin lymphoma.

Hugues de Lavallade, Philippe A Cassier, Reda Bouabdallah, Jean El-Cheikh, Catherine Faucher, Sabine Fürst, Diane Coso, Danielle Sainty, Christine Arnoulet, Jean-Albert Gastaut, Bruno Chetaille, Luc Xerri, Didier Blaise, Mohamad Mohty.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18631344     DOI： 10.1111/j.1365-2141.2008.07212.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

Review 1.  NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Transplantation.

Authors:  Steven Z Pavletic; Shaji Kumar; Mohamad Mohty; Marcos de Lima; James M Foran; Marcelo Pasquini; Mei-Jie Zhang; Sergio Giralt; Michael R Bishop; Daniel Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2010-04-24       Impact factor: 5.742

2.  NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  David L Porter; Edwin P Alyea; Joseph H Antin; Marcos DeLima; Eli Estey; J H Frederik Falkenburg; Nancy Hardy; Nicolaus Kroeger; Jose Leis; John Levine; David G Maloney; Karl Peggs; Jacob M Rowe; Alan S Wayne; Sergio Giralt; Michael R Bishop; Koen van Besien
Journal:  Biol Blood Marrow Transplant       Date:  2010-08-10       Impact factor: 5.742

3.  Outcomes of related donor HLA-identical or HLA-haploidentical allogeneic blood or marrow transplantation for peripheral T cell lymphoma.

Authors:  Jennifer A Kanakry; Yvette L Kasamon; Christopher D Gocke; Hua-Ling Tsai; Janice Davis-Sproul; Nilanjan Ghosh; Heather Symons; Javier Bolaños-Meade; Douglas E Gladstone; Lode J Swinnen; Leo Luznik; Ephraim J Fuchs; Richard J Jones; Richard F Ambinder
Journal:  Biol Blood Marrow Transplant       Date:  2013-01-29       Impact factor: 5.742

4.  Reduced-intensity allogeneic hematopoietic cell transplantation using fludarabine-melphalan conditioning for treatment of mature T-cell lymphomas.

Authors:  M Delioukina; J Zain; J M Palmer; N Tsai; S Thomas; S Forman
Journal:  Bone Marrow Transplant       Date:  2011-02-28       Impact factor: 5.483
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.